Search results
When psoriasis becomes psoriatic arthritis
Medical News Today· 1 week agoPsoriatic arthritis (PsA) is a chronic, inflammatory condition affecting the joints and tendons. It most commonly occurs in people with existing
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 2 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with ...
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 2 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 2 weeks agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape· 1 week agoThe drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
FOX 59 Indianapolis· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...
I Created a Community For the Chronically Ill. I Didn't Expect It to Save My Life.
PopSugar· 2 days agoOver two decades later, I used my lifetime of experience to build Chronicon, a community and...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 8 hours agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 2 weeks agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
VTYX IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
FOX 5 San Diego· 2 weeks agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering documents ...
